Zobrazeno 1 - 10
of 663
pro vyhledávání: '"P Y, Cheung"'
Autor:
Ziyi Qi, Tingyao Li, Jun Chen, Jason C. Yam, Yang Wen, Gengyou Huang, Hua Zhong, Mingguang He, Dan Zhu, Rongping Dai, Bo Qian, Jingjing Wang, Chaoxu Qian, Wei Wang, Yanfei Zheng, Jian Zhang, Xianglong Yi, Zheyuan Wang, Bo Zhang, Chunyu Liu, Tianyu Cheng, Xiaokang Yang, Jun Li, Yan-Ting Pan, Xiaohu Ding, Ruilin Xiong, Yan Wang, Yan Zhou, Dagan Feng, Sichen Liu, Linlin Du, Jinliuxing Yang, Zhuoting Zhu, Lei Bi, Jinman Kim, Fangyao Tang, Yuzhou Zhang, Xiujuan Zhang, Haidong Zou, Marcus Ang, Clement C. Tham, Carol Y. Cheung, Chi Pui Pang, Bin Sheng, Xiangui He, Xun Xu
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-10 (2024)
Abstract The increasing prevalence of myopia worldwide presents a significant public health challenge. A key strategy to combat myopia is with early detection and prediction in children as such examination allows for effective intervention using read
Externí odkaz:
https://doaj.org/article/039a8b13a14345e79dadae526b6c172c
Autor:
Winson Y. Cheung, Chantelle Carbonell, Vishal Navani, Randeep S. Sangha, Emmanuel M. Ewara, Julia Elia-Pacitti, Sandra Iczkovitz, Tamer N. Jarada, Matthew T. Warkentin
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4382-4396 (2024)
There is limited information on the treatment trajectory and outcomes of patients with advanced cEGFRm NSCLC treated with osimertinib in routine clinical practice in Canada. By using and analyzing population-based administrative data and detailed cha
Externí odkaz:
https://doaj.org/article/968bf2ed25324428abf61531d74ebe18
Autor:
Qi Guan, Suriya J. Aktar, Reka E. Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y. Cheung, Stuart Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C. Grant, Kelvin K. W. Chan
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3591-3602 (2024)
Niraparib was recently funded in Canada for the maintenance treatment of ovarian cancer following platinum-based chemotherapy. However, the drug’s safety profile in the real world remains uncertain. We conducted a cohort study to describe the patie
Externí odkaz:
https://doaj.org/article/7817f7dbf22f4c7abc1ea613261997ef
Publikováno v:
Pharmacoepidemiology, Vol 3, Iss 2, Pp 223-230 (2024)
Background: The paediatric use of ophthalmic chloramphenicol in New Zealand (NZ) is relatively high; however, little more is known about its utilisation, including whether this is equitable. This study aimed to describe chloramphenicol utilisation in
Externí odkaz:
https://doaj.org/article/c4c4f566827c4203a224f7b8fec014bb
Publikováno v:
International Journal of Ophthalmology, Vol 17, Iss 5, Pp 896-903 (2024)
AIM: To assess the repeatability, interocular correlation, and agreement of quantitative swept-source optical coherence tomography angiography (OCTA) optic nerve head (ONH) parameters in healthy subjects. METHODS: Thirty-three healthy subjects were e
Externí odkaz:
https://doaj.org/article/34d9008ae45d4fbba8e8cdb04a697893
Autor:
Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y. Cheung, Vishal Navani
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2427-2440 (2024)
Introduction: The use of osimertinib in the first-line (1L) setting is an effective treatment option for sensitizing EGFR-mutations (EGFRm+) and has significantly altered the standard of care practice for EGFRm+ disease in Canada. Unfortunately, acqu
Externí odkaz:
https://doaj.org/article/91ab28dc864c46b0b193ce4de85a4dd9
Publikováno v:
Cancer Medicine, Vol 13, Iss 13, Pp n/a-n/a (2024)
Abstract Background Lenvatinib (LEN) and atezolizumab + bevacizumab (A + B) have drastically changed the treatment paradigm for advanced hepatocellular carcinoma (HCC). Before these landmark trials, sorafenib (SOR) served as the standard first‐line
Externí odkaz:
https://doaj.org/article/9fffefafa3f9486a9648faba9dbbcc8e
Publikováno v:
Cancer Medicine, Vol 13, Iss 13, Pp n/a-n/a (2024)
Abstract Objectives Randomized controlled trials (RCTs) are the gold standard for evaluating the comparative efficacy and safety of new cancer therapies. However, enrolling patients in control arms of clinical trials can be challenging for rare cance
Externí odkaz:
https://doaj.org/article/919b0151574f4e5088d744bcff3ac847
Autor:
Hiu-Tung S. Wan, Darren L. L. Wong, Ching-Hang S. To, Nan Meng, Teng Zhang, Jason P. Y. Cheung
Publikováno v:
Bone & Joint Open, Vol 5, Iss 3, Pp 243-251 (2024)
Aims: This systematic review aims to identify 3D predictors derived from biplanar reconstruction, and to describe current methods for improving curve prediction in patients with mild adolescent idiopathic scoliosis. Methods: A comprehensive search wa
Externí odkaz:
https://doaj.org/article/91927f2f4d5543f2905a20bf56322f3b
Autor:
Amman Yusuf, Devon J. Boyne, Dylan E. O’Sullivan, Darren R. Brenner, Winson Y. Cheung, Imran Mirza, Tamer N. Jarada
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Laboratory data can provide great value to support research aimed at reducing the incidence, prolonging survival and enhancing outcomes of cancer. Data is characterized by the information it carries and the format it holds. Data c
Externí odkaz:
https://doaj.org/article/77ba153438d140d9b7e9a161a79c415b